Atypical E-cadherin expression in cell clusters overlying focally disrupted mammary myoepithelial cell layers: Implications for tumor cell motility and invasion

Pathology Research and Practice

Volumn 205, Issue 6, 2009, Pages 375-385

  Zhang, Xichen ^a   Hashemi, Shahreyar Shar ^b   Yousefi, Morvarid ^b   Gao, Chunling ^c   Sheng, Joy ^d   Ni, Jinsong ^e   Wang, Wan ^f   Mason, Jeffrey ^g   Man, Yan gao ^g  

^a JILIN UNIVERSITY   (China)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d APPLIED BIOSYSTEMS   (United States)

^e Basic Medical College   (China)

^f CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^g ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Breast cancer invasion; Double immunohistochemistry; E cadherin; Epithelial stromal interaction; Myoepithelial cell layer disruption

Indexed keywords

MESSENGER RNA; UVOMORULIN;

ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CANCER INVASION; CELL DISRUPTION; CELL INVASION; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ERYTHROCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOEPITHELIUM CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL;

BREAST NEOPLASMS; CADHERINS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL MOVEMENT; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; MUSCLE CELLS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67349245463     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.08.009     Document Type: Article

References (63)

1. Alam T.N., O'Hare M.J., Laczko I.I., Freeman A., Al-beidh F., Masters J.R., and Hudson D.L. Differential expression of CD44 during human prostate epithelial cell differentiation. J. Histochem. Cytochem. 52 (2004) 1083-1090
2. Barbareschi M., Pecciarini L., Cangi M.G., Macri E., Rizzo A., Viale G., and Doglioni C. p63, a p53 homologue is a selective nuclear marker of myoepithelial cells of the human breast. Am. J. Surg. Pathol. 25 (2001) 1954-1960
3. Beckmann M.W., Niederacher D., Schnurch H.G., Gusterson B.A., and Bender H.G. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J. Mol. Med. 75 (1997) 429-439
4. Bustin S.A., and Nolan T. Data analysis and interpretation. In: Busti S.A. (Ed). A-Z of Quantitative PCR (2004), International University Line, La Jolla, CA 441-492
5. Chang C.C., Sun W., Cruz A., Saitoh M., Tai M.H., and Trosko J.E. A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Radiat. Res. 155 (2001) 201-207
6. Clarke R., Brunner N., and Katzenellenbogen B.S. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc. Natl. Acad. Sci. USA 86 (1989) 3649-3653
7. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trial and tribulations. Science 295 5564 (2002) 2387-2392
8. Dontu G., AI-Hajj M., Abdallah W.M., Clarke M.E., and Wicha M.S. Stem cells in normal breast development and breast cancer. Cell. Prolif. 36 (2003) 59-72
9. Duffy M.J., Maguire T.M., Hill A., McDermott E., and O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2 (2000) 252-257
10. Eusebi V., Feudale E., Foschini M.P., Micheli A., Conti A., Riva C., Di Palma S., and Rilke F. Long-term follow-up of in situ carcinoma of the breast. Semin. Diagn. Pathol. 11 (1994) 223-235
11. Fibach E., Landau T., and Sachs L. Normal differentiation of myeloid leukaemic cells induced by a differentiation-inducing protein. Nature (London), New Biol. 237 (1972) 276-278
12. Fricke E., Keller G., Becker I., Rosivatz E., Plaschke S., Rudelius M., Hermannstadrer C., Busch R., Becker K.F., and Luber B. Relationship between E-cagherin gene mutation and p53 gene mutation p53accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma. Int. J. Cancer 104 (2003) 60-65
13. Goldfarb R.H., and Liotta L.A. Proteolytic enzymes in cancer invasion and metastasis. Semin. Thromb. Hemost. 12 (1986) 294-307
14. Guelstein V.I., Tchypysheva T.A., Ermilova V.D., and Ljubimov A.V. Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. Int. J. Cancer 53 2 (1993) 269-277
15. Handschuh G., Candidus S., Luber B., Reich U., Schott C., Oswald S., Becke H., Hutzler P., Birchmeier W., and Hofler H. Tumor-associated E-cadherin mutations alter cellular morphology decrease cellular adhesion and increase cellular motility. Oncogene 8 (1999) 4301-4312
16. Harms K., Nozell S., and Chen X. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61 (2004) 822-842
17. Heimann R., Lan F.S., McBride R., and Heilman S. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res. 60 (2000) 298-304
18. Hendrix M.J., Seftor E.A., Kirschmann D.A., Quaranta V., and Seftor R.E. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann. N. Y. Acad. Sci. 995 (2003) 151-161
19. Hunt N.C.A., DouglasJones A.G., Jasani B., Morgan J.M., and Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch. Int. J. Pathol. 430 (1997) 285-289
20. Jolicoeur F., Seemayer T.A., and Gabbiani G. Multifocal nascent, and invasive myoepithelial carcinoma (malignant myoepithelioma) of the breast: an immunohistochemical and ultrastructural study. Int. J. Surg. Pathol. 10 (2002) 281-291
21. Kordon E.C., and Smith G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 125 (1998) 1921-1930
22. Kowalski P.J., Rubin M.A., and Kleer C.G. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res. 5 (2003) R217-R222
23. Leonard G.D., and Swain S.M. Ductal carcinoma in situ complexities and challenges. J. Natl. Cancer Inst. 96 (2004) 906-920
24. Luber B., Candidus S., Handschuh G., Mentele E., Hutzler P., Feller S., Voss J., Hofler H., and Becker K.F. Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate. Cell. Adhes. Commun. 7 (2000) 391-408
25. Man Y.G. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion. Med. Hypn. 69 (2007) 1340-1357
26. Man Y.G., and Burgar A. An antigen unmasking protocol that satisfies both immunohistochemical and subsequent molecular biological assessments. Pathol.-Res.Pract. 199 (2003) 815-825
27. Man Y.G., and Nieburgs H.E. A subset of cell clusters with malignant features in morphologically Normal and hyperplastic breast tissues. Cancer Detect. Prev. 30 3 (2006) 239-247
28. Man Y.G., and Sang Q.X.A. The significance of focal myoepitehlial cell layer disruptions in breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp. Cell Res. 301 (2004) 103-118
29. Man Y.G., Martinez A., Avis I.M., Hong S.H., Cuttitta F., Venzon D.J., and Mulshine J.L. Phenotypically different respiratory epithelial cells with hnRNP A2/B1 over-expression display similar genetic alterations. Am. J. Respir. Cell Mol. Biol. 23 (2000) 636-645
30. Man Y.G., Mannion C., Albores-Saaverdra J., Bratthauer G.L., Kuhls E., and Tavassoli F.A. Allelic losses at 3p and 11p are detected in both epithelial and stromal components of cervical small cell neuroendocrine carcinoma. Appl. Immunohisthcm. Mol. Morphol. 9 (2001) 340-345
31. Man Y.G., Tai L., Barner R., Vang R., Saenger J.S., Shekitka K.M., Bratthauer G.L., Wheeler D.T., Laing C.Y., Vinh T.N., and Strauss B.L. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res. 5 (2003) R231-R241
32. Man Y.G., Magrane G.G., Lininger R.A., Shen T., Kuhls E., and Bratthauer G.L. Morphologically similar epithelial and stromal cells in primary bilateral breast tumors display different genetic profiles: implications for treatment. Appl. Immunohisthcm. Mol. Morphol. 12 (2004) 305-314
33. Man Y.G., Shen T., Weisz J., Berg P.E., Schwartz A.M., Mulshine J.L., Sang Q.X., and Nieburgs H.E. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect. Prev. 29 (2005) 323-331
34. Y.G. Man, P.E. Berg, Q.X.A. Sang, Differential expression of tumor invasion related proteins in cells overlying focally disrupted myoepithelial cell layers and adjacent cells within the same duct, in: Proceedings of Department of Defense Breast Cancer Research Program Meeting P10-5: p. 75, 2005.
35. Man Y.G., Zhang Y., Shen T., Zeng X., Tauler J., Mulshine J.L., and Strauss B.L. cDNA expression profiling identifies elevated expressions of tumor progression and invasion related genes in cell clusters of in situ breast tumors. Breast Cancer Res. Treat. 89 (2005) 199-208
36. Man Y.G., Zhao C.Q., and Wang J. Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: implications for hormonal and drug therapies. Cancer Ther. 4 (2006) 193-204
37. Y.G. Man, A. Schwartz, P. Levine, P.E. Berg, BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness. Cancer Biomarkers, in press.
38. Matrisian L.M., Sledge Jr. G.W., and Mohla S. Exacellular proteolysis and cancer: meeting summary and future directions. Cancer Res. 63 (2003) 6105-6109
39. Millis R.R., and Thynne G.S. In situ intraduct carcinoma of the breast: a long term follow-up study. Br. J. Surg. 62 (1975) 957-962
40. Miosge N. The ultrastructural composition of basement membrane in vivo. Histol. Histopathol. 16 (2001) 1239-1248
41. Moinfar F., Man Y.G., Arnould L., Bratthauer G.L., and RatConcurrent M. Independent genetic alterations in the stromal epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 60 (2000) 2562-2566
42. Moinfar F., Gogg-Kamerer M., Sommersacher A., Regitnip P., Man Y.G., Zatloukal K., Denk H., and Tavassoli F.A. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR HER-1): potential basis for a new therapeutic approach. Am. J. Surg. Pathol. 29 (2005) 485-489
43. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., and Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57 (1997) 3305-3313
44. Nanba D., Nakanishi Y., and Hieda Y. Changes in adhesive properties of epithelial cells during early morphogenesis of the mammary gland. Dev. Growth Differ. 43 (2001) 535-544
45. Oka H., Shiozaki H., Kobayashi K., Inoue M., Tahara H., Kobayashi T., Takatsuka Y., Matsuyoshi N., and Hirano S. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53 (1993) 1696-1701
46. Page D.L., Duppont W.D., Rogers L.W., and Landenberger M. Intraductal carcinoma of the breast: follow up after biopsy only. Cancer 49 (1982) 751-758
47. Page D.L., Dupont W.D., Rogers L.W., Jensen R.A., and Schuyler P.A. Continues local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76 (1995) 1197-2000
48. Parker S.L., Tong T., Bolders S., and Wingo P.A. Cancer statistics. Cancer J. Clin. 47 (1997) 5-27
49. Pishvarian M.J., Feltes C.M., Thompson P., Bassemakers M.J., Schalken J.A., and Byers S.W. Cadherin-11 is expressed in invasive cancer cell lines. Cancer Res. 59 (1999) 947-952
50. Schmidt D.S., Klingbeil P., Schnolzer M., and Zoller M. CD44 variant isoforms associate with tetraspanins and EpCAM. Exp. Cell Res. 297 (2004) 329-347
51. Sell S., and Pierce G.B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 70 (1994) 6-22
52. Shore E.M., and Nelson W.J. Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Derby canine kidney epithelial cells. J. Biol. Chem. 266 (1991) 19672-19680
53. Siitonen S.M., Kononen J.T., Helin H.J., Rantala I.S., Holli K.A., and Isola J.J. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 105 (1996) 394-402
54. Silberstein G.B. Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res. 3 (2001) 218-223
55. Sternlight M.D., and Barsky S.H. The myoepithelial defense: a host defense against cancer. Med. Hypotheses 48 (1997) 37-46
56. Tavassoli F.A., and Man Y.G. Morphofunctional features of intraductal hyperplasia atypical hyperplasia, and various grades of intraductal carcinoma. Breast J. 1 3 (1995) 155-162
57. Tsubura A., Shikata N., Inui T., Morii S., Hatano T., Oikawa T., and Matsuzawa A. Immunohistochemical localization of myoepithelial cells and basement membrane in normal benign and malignant human breast lesions. Virchows Arch. 413 (1988) 133-139
58. Yousefi M., Mattu R., Gao C., and Man Y.G. Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: implications for tumor progression and invasion. Appl. Immunohisthcm Mol. Morphol. 13 (2005) 30-37
59. Zaugg K., and Bodis S. Is there role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?. Radiother. Oncol. 55 (2000) 95-99
60. Zhang R., Man Y.G., Vang R.S., Saenger J.S., Barner R., Wheeler D., Liang C.Y., Vinh T.N., and Bratthauer G.L. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res. 5 (2003) R151-R156
61. Zhao Y.G., Xiao A.Z., Park H.I., Newcomer R.G., Yan M., Man Y.G., Heffelfinger S.C., and Sang Q.S.A. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinase-2 and 4: a putative role in the initiation of breast cancer invasion. Cancer Res. 64 (2004) 590-598
62. Zhu G., Reynolds L., Crnogorac-Jurceic T., Gillett C.E., Dublin E.A., Marshall J.F., Barnes D., D'Arrigo C., Van Trappen P.O., Lemoine N.R., and Hart I.R. Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells of breast cancer. Oncogene 22 (2003) 3742-3748
63. Zou Z., Anisowicz A., Hendrix M.J., Thor A., Neveu M., Sheng S., Rafidi K., Seftor E., and Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263 (1994) 526-529